Ottobock SE & Co. KGaA (ETR:OBCK)

Market Cap	3.24B
Revenue (ttm)	1.69B +5.4%
Net Income	91.80M +96.4%
EPS	n/a
Shares Out	63.99M
PE Ratio	35.34
Forward PE	16.91
Dividend	0.97 (1.91%)
Ex-Dividend Date	May 20, 2026

Volume	20,347
Open	50.50
Previous Close	50.70
Day's Range	50.00 - 50.80
52-Week Range	45.56 - 76.35
Beta	n/a
Analysts	Strong Buy
Price Target	81.75 (+61.88%)
Earnings Date	Aug 13, 2026

About Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of prosthetics, neuro-orthotics, and digital solutions; prostheses for the upper and lower extremities; mechanical prostheses and technologically sophistic...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1919
• Employees: 10,365
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: OBCK

Financial Performance

In 2025, Ottobock SE & Co. KGaA's revenue was 1.68 billion, an increase of 4.69% compared to the previous year's 1.60 billion. Earnings were 90.20 million, an increase of 198.68%.

Analyst Summary

According to 8 analysts, the average rating for OBCK stock is "Strong Buy." The 12-month stock price target is €81.75, which is an increase of 61.88% from the latest price.

Price Target

€81.75

(61.88% upside)

Analyst Consensus: Strong Buy